Daily non-political popular news in brief.

Decline in breast cancer cases likely linked to reduced use of hormone replacement

In 2003, breast cancer incidence in the United States dropped sharply, and this decline may largely be due to the fact that millions of older women stopped using hormone replacement therapy (HRT) in 2002, according to a new analysis led by researchers at the University of Texas M. D. Anderson Cancer Center.

Read more »

Keywords: decline, breast, cancer, cases, likely, linked, reduced, hormone, replacement, case

« Previous | Next »

Similar news on "Decline in breast cancer cases likely linked to reduced use of hormone replacement":

1. Decrease in breast cancer incidence linked to drop in hormone replacement
   04-18-2007 · EurekAlert!
   A special report in the April 19, 2007, edition of the New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative and the ensuing drop in hormone-replacement therapy among postmenopausal women.
   Similar news · Read more »
   
2. Drop in breast cancer incidence linked to hormone use, not mammograms
   08-14-2007 · EurekAlert!
   A recent decline in breast cancer incidence is unlikely to be caused by a decrease in mammography screening, according to a study published online Aug. 14 in the Journal of the National Cancer Institute. It is more likely due to the drop in postmenopausal hormone use.
   Similar news · Read more »
   
3. Decrease in breast cancer rates related to reduction in use of hormone replacement therapy
   04-18-2007 · EurekAlert!
   The sharp decline in the rate of new breast cancer cases in 2003 may be related to a national decline in the use of hormone replacement therapy (HRT). Age-adjusted breast cancer incidence rates in women in the United States fell 6.7 percent from 2002 to 2003. Prescriptions for HRT also declined rapidly in 2002 and 2003.
   Similar news · Read more »
   
4. Breast cancer incidence continues to trend low in 2004; decline supports role of HRT
   04-18-2007 · EurekAlert!
   An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy and increased breast cancer incidence, according to research led by scientists at the University of Texas M. D. Anderson Cancer Center and published in the April 19 issue of the New England Journal of Medicine.
   Similar news · Read more »
   
5. Why are African American women more likely than whites to die from breast cancer?
   02-21-2007 · EurekAlert!
   Why are African American women 1.5 to 2.2 times more likely than white women to die from breast cancer, despite their lower incidence of the disease? The reason may not be solely reduced access to medical care, researchers suggest in the International Journal of Surgery. They propose that the excess mortality occurs partly because black women are more likely to develop breast cancer before menopause, when surgery may be more apt to stimulate cancer growth.
   Similar news · Read more »
   
6. Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy
   05-15-2007 · EurekAlert!
   Hormone replacement therapy (HRT) can reduce many cardiovascular disease (CVD) risks, but many women have stopped using HRT due to reports that HRT may increase the risk of breast cancer and heart disease. In a study published in the June issue of the American Journal of Preventive Medicine, researchers from the University of Pittsburgh Graduate School of Public Health examined whether the increased CVD risk from stopping HRT could be minimized by lifestyle change intervention.
   Similar news · Read more »
   
7. Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
   01-15-2008 · EurekAlert!
   Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
   Similar news · Read more »
   
8. Many women get less chemo than recommended
   01-18-2007 · EurekAlert!
   Women with breast cancer who are obese or less educated are twice as likely to get reduced doses of chemotherapy than doctors recommended, jeopardizing survival, according to scientists at the University of Rochester Medical Center.
   Similar news · Read more »
   
9. Soy estrogens and breast cancer: Researcher offers overview
   05-16-2007 · EurekAlert!
   Are soy products healthy additions to a person’s diet, safe alternatives to hormone-replacement therapy or cancer-causing agents? The answer, according to University of Illinois food science and human nutrition professor William Helferich, is, "It depends."
   Similar news · Read more »
   
10. Poorer women more likely to get reduced chemotherapy dose, study finds
    01-18-2007 · EurekAlert!
    Breast cancer patients who have a lower household income and less education may be more likely to receive reduced doses of chemotherapy, according to a new study from a University of Michigan Comprehensive Cancer Center researcher.
    Similar news · Read more »